相关实验视频
Updated: Jun 14, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
[基于生物系统中新出现的复杂性的生物学和药理学反应理解的挑战:从骨代谢到一般生理学]
1Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo.
了解复杂的生物系统,如涉及RANK/RANKL的骨代谢,是一项挑战. 像顺序模拟和全系统约束这样的新方法改善了用于生物见解和药物效应分析的数学建模.
科学领域:
- 系统生物学 系统生物学
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物系统是复杂的,知识的积累往往阻碍了整合性理解.
- 在骨代谢中,核因子kappa B (RANK) 的受体激活剂及其连接体 (RANKL) 是细胞类型之间的复杂性的例子.
- 系统生物学强调探索复杂的生物网络中的相互作用.
研究的目的:
- 为了解决生物系统的数学建模由于参数可用性和可靠性的局限性.
- 提出和验证新的分析方法,以了解生物动态和药物效应.
- 提高对复杂的生物事件及其扰动的理解.
主要方法:
- 开发和应用顺序模拟来分析动态模型.
- 实施系统范围的行为约束,源自恒温,以减少参数搜索空间.
- 基于模型分析特定的生物通路,包括sunitinib毒性和NSAID对酸通路的影响.
主要成果:
- 顺序模拟成功地在更大的网络中重现了行为,帮助毒性分析.
- 全系统的约束在大规模模型中显著减少了参数搜索空间.
- 提出的方法提供了对生物系统动态和药物效应的见解.
结论:
- 序列模拟和全系统约束是分析复杂生物系统的有效方法.
- 这些方法提高了数学模型在生物学和药理学中的可靠性和适用性.
- 改进的建模有助于更深入地了解生物过程和药物相互作用.
更多相关视频
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Factors Affecting Drug Response: Overview
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .